Jessica wasserman, 
Science & regulatory affairs Committee

As the founder of Washington-DC based law and regulatory policy firm WassermanRowe, Jessica Wasserman brings to the board decades of experience as a practitioner representing highly regulated industries before federal agencies, including at the Food and Drug Administration on behalf of  food, beverage, wellness and medical device companies.   Jessica gets into the nitty gritty of premarket approvals, withdrawals, recalls, labeling and claims for FDA-regulated food, drugs, dietary supplements, medical devices, cosmetics, petfood and tobacco/vape products. Most recently, Jessica is proud of her role in assisting Covid 19 test developers to receive FDA Emergency Use Authorizations, necessary to get these important tests on the market. 

 

Jessica has worked since 2018, when hemp was de-scheduled, assisting hemp and CBD companies to commercialize their products.  She has also donated many hours working on behalf of the industry as a whole in advocacy efforts toward a regulatory pathway at FDA for the marketing of CBD products.

With experience working on Capitol Hill and as a political appointee at the Departments of Agriculture and Commerce, Jessica has a 360-degree view of the legislative, regulatory, and political path toward cannabis legalization.

Jessica is a graduate of St. John’s College and the University of Michigan Law School.